Manatt Represents A.G.P./Alliance Global Partners in $20 Million At-the-Market Offering for FSD Pharma, Inc.

Thomas Poletti and Katherine Blair, partners in Manatt’s capital markets practice, represented A.G.P./Alliance Global Partners as sales agent in a $20 million at-the-market offering of Class B Subordinate Voting Shares of FSD Pharma Inc., a Canadian company that trades on Nasdaq and the Canadian Securities Exchange. FSD Pharma, through its wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound FSD-201, by down-regulating the cytokines to effectuate an anti-inflammatory response.

The Manatt team, led by Poletti and Blair, also included associate Jonathan Brecher.



pursuant to New York DR 2-101(f)

© 2023 Manatt, Phelps & Phillips, LLP.

All rights reserved